GVCCX
Price
$6.98
Change
-$0.03 (-0.43%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

GVCCX vs VMCPX

Header iconGVCCX vs VMCPX Comparison
Open Charts GVCCX vs VMCPXBanner chart's image
Gabelli Value 25 C
Price$6.98
Change-$0.03 (-0.43%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GVCCX vs VMCPX Comparison Chart
Loading...
VS
GVCCX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVCCX is a Buy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. GVCCX (219M). VMCPX pays higher dividends than GVCCX: VMCPX (1.51) vs GVCCX (0.00). GVCCX was incepted earlier than VMCPX: GVCCX (25 years) vs VMCPX (14 years). VMCPX is a more actively managed with annual turnover of: 13.00 vs. GVCCX (6.00). GVCCX has a lower initial minimum investment than VMCPX: GVCCX (1000) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 25.17 vs. GVCCX (6.24). VMCPX return over 5 years is better than : 56.93 vs. GVCCX (-35.79).
GVCCXVMCPXGVCCX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years14 years-
Gain YTD11.14612.59389%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets219M172B0%
Annual Yield % from dividends0.001.51-
Returns for 1 year6.2425.1725%
Returns for 3 years-33.669.85-342%
Returns for 5 years-35.7956.93-63%
Returns for 10 years-58.61128.75-46%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMFG12.870.16
+1.26%
Sumitomo Mitsui Financial Group
KTCC5.240.02
+0.38%
Key Tronic Corp
DDS368.160.65
+0.18%
Dillards
JSPR23.88-0.03
-0.13%
Jasper Therapeutics
AHCO11.25-0.05
-0.44%
AdaptHealth Corp